Zobrazeno 1 - 10
of 157
pro vyhledávání: '"Odd Erik Johansen"'
Autor:
Anne Pernille Ofstad, Cathrine Brunborg, Odd Erik Johansen, Bjørn Mørkedal, Morten W. Fagerland, Lars Erik Laugsand, Lars L. Gullestad, Håvard Dalen
Publikováno v:
ESC Heart Failure, Vol 10, Iss 5, Pp 2807-2815 (2023)
Abstract Aims Currently, no incident heart failure (HF) risk score that is in regular use in a general population is available. We aimed to develop this and compare with existing HF risk scores. Methods and results Participants in the third wave (200
Externí odkaz:
https://doaj.org/article/8a9ad96af99e4d6fbbd3d40811116c9e
Autor:
Jiří Vosáhlo, Adam Salus, Michael Smolko, Barbora Němcová, Veit Nordmeyer, Milos Mikles, Stefanie M. Rau, Odd Erik Johansen
Publikováno v:
Therapeutic Advances in Musculoskeletal Disease, Vol 15 (2023)
Background: Early mobilization after total hip replacement (THR) is key for fast recovery but is often limited by pain. Oral enzyme combinations (OECs) have demonstrated anti-inflammatory and pain-relieving effects. Objectives and design: This prospe
Externí odkaz:
https://doaj.org/article/ce96fa081d4449d9a91ea485ebe06b6a
Autor:
Odd Erik Johansen, Delphine Curti, Maximilian von Eynatten, Andreas Rytz, Anirban Lahiry, Frederik Delodder, Gerhard Ufheil, Carmine D’Urzo, Audrey Orengo, Kate Thorne, Jaclyn S. Lerea-Antes
Publikováno v:
Nutrients, Vol 15, Iss 12, p 2752 (2023)
In this randomized, double-blind triple-crossover study (NCT05142137), the digestive tolerance and safety of a novel, slowly digestible carbohydrate (SDC), oligomalt, an α-1,3/α-1,6-glucan α-glucose-based polymer, was assessed in healthy adults ov
Externí odkaz:
https://doaj.org/article/a43607ea646e44f19a0feda0e0fc66e9
Autor:
Darren K. McGuire, Silvio E. Inzucchi, Odd Erik Johansen, Julio Rosenstock, Jyothis T. George, Nikolaus Marx
Publikováno v:
Journal of Pharmaceutical Policy and Practice, Vol 14, Iss 1 (2021)
Hyperglycemia is an undisputed epidemiological risk factor for microvascular complications in both type 1 and type 2 diabetes, integral in their causal pathways. Importantly, interventions that reduce the hyperglycemic burden in patients with either
Externí odkaz:
https://doaj.org/article/d10cb6666c9b4412859efa118e071efc
Autor:
Satish Arora, Anne Pernille Ofstad, Geir R. Ulimoen, Kåre I. Birkeland, Knut Endresen, Lars Gullestad, Odd Erik Johansen
Publikováno v:
Cardiovascular Diabetology, Vol 18, Iss 1, Pp 1-9 (2019)
Abstract Aims The prevalence of asymptomatic coronary artery disease (CAD) in type 2 diabetes (T2D) is unclear. We investigated the extent and prevalence of asymptomatic CAD in T2D patients by utilizing invasive coronary angiography (ICA) and intrava
Externí odkaz:
https://doaj.org/article/821b761f4653459fa9a4339c4f60a165
Autor:
Surinder S Birring, May Brit Lund, Michael T Durheim, Tomas M Eagan, Arnt-Ove Hovden, Gisle Bjerke, Trygve M Jonassen, Odd Erik Johansen, Tone Sjåheim
Publikováno v:
BMJ Open Respiratory Research, Vol 7, Iss 1 (2020)
Introduction Idiopathic pulmonary fibrosis (IPF) and systemic sclerosis-associated interstitial lung disease (SSc-ILD) are fibrotic ILDs with divergent disease populations. Little is known about health-related quality of life (HRQL) in SSc-ILD relati
Externí odkaz:
https://doaj.org/article/a4825a34114d484892230718bb861202
Autor:
Geert Jan Biessels, Jolien Janssen, Esther van den Berg, Bernard Zinman, Mark A. Espeland, Michaela Mattheus, Odd Erik Johansen, on behalf of the CAROLINA® investigators
Publikováno v:
BMC Neurology, Vol 18, Iss 1, Pp 1-10 (2018)
Abstract Background Type 2 diabetes mellitus is associated with cognitive dysfunction and an increased risk of dementia. Linagliptin is a glucose-lowering agent of the dipeptidyl peptidase-IV (DPP-IV) inhibitor class that is of particular interest fo
Externí odkaz:
https://doaj.org/article/cec3f4073ada4aab9be5a3f9c29f8d8c
Autor:
Vladimer Darsalia, Odd Erik Johansen, Grazyna Lietzau, Thomas Nyström, Thomas Klein, Cesare Patrone
Publikováno v:
Frontiers in Neurology, Vol 10 (2019)
Cerebral stroke is a leading cause of death and persistent disability of elderly in the world. Although stroke prevention by targeting several risk factors such as diabetes and hypertension has decreased the stroke incidence, the total number of stro
Externí odkaz:
https://doaj.org/article/644eaad974d746899b7d4c74e8260257
Autor:
Bruce A Perkins, David Z I Cherney, Nima Soleymanlou, Justin A Lee, Helen Partridge, Holly Tschirhart, Bernard Zinman, Roger Mazze, Nora Fagan, Stefan Kaspers, Hans-Juergen Woerle, Uli C Broedl, Odd Erik Johansen
Publikováno v:
PLoS ONE, Vol 10, Iss 11, p e0141085 (2015)
We recently reported improved glycemic control with reduced insulin dose in subjects with type 1 diabetes treated with the sodium glucose co-transporter-2 inhibitor empagliflozin. To further characterize the effects, we analyzed diurnal glycemic patt
Externí odkaz:
https://doaj.org/article/b2c437cf61584b079e016ba149dba298
Autor:
Mafauzy Mohamed, Roberto Luis Zagury, Kalpana Bhaskaran, Joel Neutel, Barakatun Nisak Mohd Yusof, Linda Mooney, Lihe Yeo, Bridget-Anne Kirwan, Olivier Aprikian, Maximilian von Eynatten, Odd Erik Johansen
Publikováno v:
Diabetes Therapy. 14:749-766